Aspen Notre-Dame-de-Bondeville is an international production site that has specialised in the manufacture of sterile injectable forms since 1968.

Aspen Notre-Dame-de-Bondeville manufactures Fraxiparine™ and Arixtra™ for worldwide distribution.

All manufacturing steps are performed and checked on site, in a spirit of continuous improvement, in accordance with the systematic Lean Six Sigma approach:

  • Chemical production to transform the essential raw material for the formulation of active ingredients
  • Sterile filling
  • Automatic inspection
  • Packaging
  • All the way through the shipping of syringes to our customers

Aspen Notre-Dame-de-Bondeville has the ambition to become the world leader in thrombosis drugs.


2 active ingredients

5 products

More than 140 million units shipped each year

90% of our thrombosis drugs are exported worldwide

More than 330 references shipped

3,391 production orders 

677 employees

Founded in 1968

Our certifications: ANVISA (Brazil), ANSM (France), EMA (Europe), FDA (USA), HPB (Canada), JMHRA (Japan)

Aspen has a Management System certified by DQS for OHSAS 18001 (Health / Safety) and ISO 14001 (Environment) standards


Investor/Investisseurs Information


Site Presentation

Download PDF